CHINA MED CLEAR VISION FORMULA QI JU DI HUANG TANG

CHINAMED CLEAR VISION FORMULA QI JU DI HUANG TANG

This is a widely used variant of Liu Wei Di Huang Wan (Rehmannia Six Formula), which was first recorded in the Precious Mirror for Advancement of Medicine (yi ji bao jian) by Dong Xi-xuan, 1777. In contrast to Rehmannia Six Formula (which mainly threats the Kidney), the therapeutic actions of this formula are focused mainly on the Liver to address Liver Blood deficiency and Liver Yin deficiency. It was originally developed in order to treat disorders of the eyes, with the features of dry eyes, poor visual acuity, photophobia, excessive lacrymation, etc.

In addition to treating chronic eye conditions, this formula has a broad range of applications in disorders due to Liver and Kidney Yin deficiency, possibly also with hyperactivity of the Liver Yang. These include chronic headaches, dizziness and hypertension. It should be noted that this formula is not suitable for acute infections of the eye. The main clinical features, as listed above, should be present in order for this formula to be indicated.

Black Pearl approximate equivalent formula Qi Ju Di Huang Wan (Lycium, Chrysanthemum & Rehmannia BP017)

– Rehmannia glutinosa, root 地黃 462.2 mg
– Dioscorea oppositifolia, root 山藥 232.2 mg
– Cornus officinalis, fruit 山茱萸 232.2 mg
– Wolfiporia cocos, hyphae 茯苓 174.6 mg
– Alisma plantago aquatica, rhizome 澤瀉 174.6 mg
– Lycium barbarum, fruit 枸杞子 174.6 mg
– Chrysanthemum sinense, flower 菊花 174.6 mg
– Paeonia suffruticosa, stem bark 牡丹皮 174.6 mg

Signs & Symptoms
– Hypertension
– Meniere’s disease
– Excessive lacrimation
– Photophobia
– Migraine
– Blurred vision
– Cataracts, early stage
– Retinitis
– Eye and vision, chronic disorders (eg. Central retinochoroiditis, retrobulbar neuritis, optic nerve atrophy, vitreous opacity, glaucoma, retinal disorders, cataracts)
– Dry eyes, chronic
– Eyes, itchy red
– Night sweats
– Optic nerve atrophy
– Optic neuritis
– Retinal degeneration

Dosage & Course of Treatment
– 3 – 4 capsules, 2 – 3 times daily.
– In severe cases and in the early stages of treatment (first 1 – 2 weeks) the dosage may be increased by 50%.
– Course of treatment: 3 – 9 months, or ongoing in elderly patients.
– Safe for long term use.

Cautions & Contraindications
– Discontinue during an episode of common cold or influenza. Not for acute inflammatory eye diseases.